Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All Diagnostic Tests Articles

Brain-induced pain, as opposed to inflammatory or neuropathic pain, may call for unique diagnoses and treatment plans.
Alcohol monitoring of urine in patients receiving long-term opioid therapy can be a useful tool.
A guide to selecting the right tests to properly diagnose rheumatic disorders
In this month's Editor's Memo, Forest Tennant, MD, DPH, discusses the importance of recognizing and promoting optimum flow of spinal fluid to improve pain management for patients.
This case report presents the use of pharmacogenetic testing to help improve pain management and reduce adverse drug effects, with a result of appropriate medication changes to reflect his cytochrome P450 (CYP) profile.
Learn more about the critical role hormones play in promoting analgesia, neuroprotection, healing, and neurogenesis.
Dr. Forest Tennant discusses the current status of pharmacogenetic testing in pain management.
This article presents an up-to-date status and review of the clinical use and interpretation of the common pharmacogenetic markers that have relevance to pain management.
An interview with Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP
An estimated 20 million Americans smoke marijuana. Having a positive urine drug screen, therefore, may not be unusual—except if the patient swears they don't smoke pot. Learn why non-smokers may test positive for marijuana.
What can cause a false positive urine drug screening for benzodiazepines? Our expert ask your questions.
Question: What can cause a false positive urine drug screening for amphetamine?
When a clinician orders urine drug testing for a patient prescribed chronic opioid therapy (COT), it is essential that the results are interpreted correctly because they often have significant clinical implications. A positive test result showing drugs and/or metabolites found in urine is easily understood.
Hormone profile testing is readily available and may be recommended for any chronic pain patient who is not achieving good pain control with their current medical regimen.
Pain management physicians have been presented with a conundrum: providing patients with the best care available while preventing the misuse, abuse, and diversion of opioid pain medications. This often places the clinician in opposing roles—health care provider sworn to first do no harm and amateur drug enforcement agent. How can caring physicians walk this ethical tightrope?